Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$232.23−4.75 (-2.00%)
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Masimo Corporation by Year
Masimo Corporation — Clinical Trials Started During the Year (cumulative total of 105 studies)
Danaher Masimo Corporation: 3 in FY2025, unchanged from a year earlier. That is the lowest of the 10 years on record here.
Latest, FY2025
3
Period ended Dec 31, 2025
Change on a year earlier
0.0%
3 in FY2024
History
10 years
Since FY2016
Sources
1
NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry)
Where the FY2025 figure comes from
Source: NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗
Reported in NIH ClinicalTrials.gov API v2.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Masimo Corporation — Clinical Trials Started During the Year (cumulative total of 105 studies) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | 0.0% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2024 | Dec 31, 2024 | 3 | -70.0% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2023 | Dec 31, 2023 | 10 | +25.0% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2022 | Dec 31, 2022 | 8 | +166.7% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2021 | Dec 31, 2021 | 3 | -40.0% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2020 | Dec 31, 2020 | 5 | -54.5% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2019 | Dec 31, 2019 | 11 | -35.3% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2018 | Dec 31, 2018 | 17 | +142.9% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2017 | Dec 31, 2017 | 7 | -50.0% | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
| FY2016 | Dec 31, 2016 | 14 | – | NIH ClinicalTrials.gov API v2 (Lead-Sponsor Study Registry) ↗ |
Cite this data
StockData. (2026). Danaher Masimo Corporation, annual FY2016–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-ct-studies-masimo
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.